Navigation Links
The Feinstein to collaborate with Sweden's Karolinska Institute
Date:4/9/2008

MANHASSET, NY As part of its global mission of advancing science, The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden. The agreement paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from The Feinstein to study at the Karolinskas laboratories in Stockholm.

The Karolinska Institutet is always looking for outstanding training environments for their graduates, said Kevin J. Tracey, MD, director and chief executive of The Feinstein. And we want the students of our Elmezzi Graduate School of Molecular Medicine to have a challenging post-doctoral career as well. It couldnt be a better fit.

According to the agreement, both institutes have established joint programs to enhance the training and research of each institutes students and post-doctoral researchers. The collaboration will mean that as many as half a dozen scientists may be able to study abroad and that Feinstein scientists can host an equal number of Karolinskas post-doctoral students. They will still have to apply for a seat in the lab in New York or abroad, and a joint admissions committee from both institutes will review the applications and make the selections.

Our mission is translational research, and we offer a progressive basic and clinical training environment, added Dr. Tracey, an immunologist who collaborated with Karolinskas Jan Andersson, M.D., the head of infectious diseases, studying cytokines and inflammation. Dr. Andersson was also the first invited lecturer for The Feinstein Institutes Marsh lecture in 2005. His research includes the study of the potential role of regulatory T-cells in HIV/AIDS. He has discovered that HIV infection is associated with an increase of regulatory T-cells that negatively affect the capacity to mount a fully functional CD8 T-cell response against the infection. These regulatory T-cells could become a target for future treatments to reconstitute the immune system damaged by HIV infection.

The graduate students at the Karolinska and The Feinstein are medical doctors who have gone on to obtain a doctoral degree in research. The faculty leadership is always looking for the best and brightest post-doctoral students, said Dr. Tracey. These students are the heart of the lab.


'/>"/>

Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
2. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
3. INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement
4. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
5. The National ePrescribing Patient Safety Initiative Collaborates With Google
6. Quest Diagnostics to Collaborate with Google on New Health Offering
7. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
8. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
9. Cleveland Clinic Collaborates with Google
10. BayCare Health System Collaborates With Accenx to Provide Reliable Exchange of Information
11. Geisinger and Celera to collaborate on liver disease test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is ... Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases their ... title in 2015, this marks the 3rd time that Dr. Canales has ...
(Date:6/22/2017)... ... 22, 2017 , ... Children’s National Health System ... to launch a Rheumatic Heart Disease Center, with the goal of developing innovative ... disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the United ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work in countries ... where the rule of law has been degraded. The PSC.1 standard was created ...
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... ... , ... After months of negotiations, FaceCradle USA is proud to announce the debut of ... “Introducing our product on QVC is something we all worked hard to achieve for many ... than 90 million homes in the United States,” said FaceCradle USA President Dylan Doherty. “We ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... June 16, 2017  Exactly 50 years ago today, the ... later became known as the San Francisco "Summer of Love."  ... unveiling two radical innovations in strategic market research portals that ... marks the beginning of Northern Light,s "Summer of Love (For ... ...
(Date:6/13/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... and Drug Administration (FDA) has notified the Company that the ... Zhejiang, China manufacturing facility has been closed ... of the Warning Letter related to our ... the progress we have made in our ongoing quality and ...
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
Breaking Medicine Technology: